Rewatch key moments from the event
As cell and gene therapies offer newfound hope to patients, the journey to commercialization is fraught with obstacles. The need for greater efficiency, improved safety, and inventive approaches to pricing and access is paramount. Tackling these challenges was the motivation behind Cell & Gene Day 2023.
Hosted by Endpoints News and co-sponsored by Precision ADVANCE, Center for Breakthrough Medicines, and Alliance for Regenerative Medicine, Cell & Gene Day 2023 showed us the most recent insights on cell and gene therapy research, development, manufacturing, and commercialization.
Through six panel discussions, we explored topics together with accomplished experts from across the advanced therapy field, including representatives from the University of Pennsylvania, Blackstone, Alliance for Regenerative Medicine (ARM), Iovance Biotherapeutics, Spark Therapeutics, Kate Therapeutics, RegenXBio, and more.
State of the Industry Briefing
Innovations, Challenges and Perspectives for Advanced Therapies
Approvals and Market Access for Cell and Gene Therapies
Moving Clinical Development Forward
